Introduction
============

Age-related macular degeneration (AMD) is an age-associated macular disease, and the most common disease of blindness in people \>60 years old ([@b1-ijmm-43-02-0936]). Its main feature is the retinopathy of the retina and choroid, which causes decreased visual function and reduced central vision in particular ([@b2-ijmm-43-02-0936]). Oxidative stress serves a vital role in the pathogenesis of AMD ([@b3-ijmm-43-02-0936]). Retinal pigment epithelial (RPE) cells, as the most metabolically active type of cellin eye tissue, can engulf the outer disc of the retina photoreceptor cells and produce a large number of lipid peroxides and H~2~O~2~ ([@b4-ijmm-43-02-0936]). Furthermore, the photo-oxidation effect occurs when RPE is illuminated over long durations ([@b5-ijmm-43-02-0936]). Therefore, RPE has a higher susceptibility to oxidative stress. In addition, due to aging, the resistance of the antioxidant system of RRE declines ([@b6-ijmm-43-02-0936],[@b7-ijmm-43-02-0936]). Oxidative stress and decreased antioxidant capacity may lead to functional disorders and structural abnormalities of the RPE, which have been identified as important pathological alterations associated with AMD ([@b3-ijmm-43-02-0936],[@b6-ijmm-43-02-0936],[@b7-ijmm-43-02-0936]).

Genipin (GP), is a glycosidic ligand derived from iridoid glycosides and is widely distributed in plants, including Mast and *Eucommia ulmoides*. GP is the main metabolite of geniposide in humans or animals, and is also the main active form with pharmacokinetic function ([@b8-ijmm-43-02-0936]). Studies have demonstrated that GP has certain properties, including anti-infection, anti-inflammation, antioxidation and antitumor ([@b9-ijmm-43-02-0936]-[@b12-ijmm-43-02-0936]). In addition, GP has been widely regarded as a specific inhibitor of uncoupling protein 2 (UCP2) ([@b13-ijmm-43-02-0936]). UCP2 is a functional protein in the mitochondrial inner membrane, which regulates the proton pump of mitochondria ([@b14-ijmm-43-02-0936]). Specifically, UCP2 is involved in modulating the opening of the ion channels on the mitochondrial membrane, inhibiting the production of reactive oxygen species (ROS), there by suppressing the apoptosis of cells and damage to mitochondria ([@b15-ijmm-43-02-0936]). However, the role of GP on RPE cell injury induced by oxidative stress is unknown.

Nuclear factor-erythroid 2-related factor-2 (Nrf2), as a transcription factor, serves a vital function in opposing cell damage due to endogenous and exogenous stresses ([@b16-ijmm-43-02-0936]). It is well known that Nrf2 is a main regulator of the antioxidant reaction, which can control the antioxidant response element-regulated the expression of phase II and antioxidant enzymes, including heme oxygenase-1 (HO-1) and NAD(P)H: Quinine oxidoreductase 1 (NQO1) ([@b17-ijmm-43-02-0936],[@b18-ijmm-43-02-0936]). It has been reported that antioxidants protect oxidative stress-induced RPE cells by activating Nrf2 signaling ([@b19-ijmm-43-02-0936]).

The present study, aimed to establish an RPE cell oxidative stress injury model; H~2~O~2~ acts as an inducer of oxidative damage to RPE cells ([@b20-ijmm-43-02-0936]). In addition, the effects of GP on H~2~O~2~-induced RPE cells were determined and whether the underlying molecular mechanism is associated with Nrf2 signaling was investigated in the present study.

Materials and methods
=====================

Cell culture and transfection
-----------------------------

Human RPE cell lines (ARPE-19 cells) were obtained from the American Type Culture Collection (Manassas, VA, USA), which were maintained in Dulbecco's modified Eagle's medium/Nutrient F12 Ham (DMEM/F12; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany), which contained 10% fetal bovine serum (FBS; HyClone; GE Healthcare Life Sciences, Logan, UT, USA), 100 *µ*g/ml streptomycin and 100 U/ml penicillin (Beijing Solarbio Science & Technology, Co., Ltd., Beijing, China) in a humidified incubator with 5% CO~2~ at 37°C (80G-2, Shanghai Huafu Instrument Co. Ltd.).

ARPE-19 cells were transfected with pSilencer 2.1 vector (1 *µ*g, Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing small interfering (si)RNA negative control (NC; 5′-CAC ACT GGA TGG CCT AGG AGG ATA T-3′) or siRNA Nrf2 (siNrf2;5′-CAC ACT GGA TCA GAC AGG AGG ATA T-3′) vectors using Lipofectamine^®^ 3000 (Thermo Fisher Scientific, Inc.). After transfection, cells were incubated for 24 h and then used for subsequent experimentation; untreated cells served as the control.

Methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay
-------------------------------------------------------

An MTT kit (Beyotime Institute of Biotechnology, Shanghai, China) was employed to measure cell viability. ARPE-19 cells were seeded into 96-well plates (2×10^3^ cell/well) for 24 h. Cells were exposed to various concentrations of H~2~O~2~ (0, 10, 50, 100, 200, 400 and 800 *µ*M) and GP (0, 5, 10, 30, 50 and 100 *µ*M) for 24 h at 37°C, respectively. Other cells were transfected with NC and siNrf2 vectors as aforementioned. Then, cells were incubated with MTT solution for 4 h at 37°C. Subsequently, the supernatant was removed; dimethyl sulfoxide was then added to the cells and the optical density at 490 nm was evaluated using a microplate reader (SpectraMax iD3, Molecular Devices, LLC, Sunnyvale, CA, USA); 200 *µ*M H~2~O~2~ was finally used to treat cells in the subsequent experiments.

Flow cytometry
--------------

For the analysis of ROS, a ROS assay kit (Beyotime Institute of Biotechnology) was employed according to the manufacturer's protocols. In brief, cells were seeded into 6-well plates (5×10^4^ cell/well) for 24 h. Then, cells were treated with 200 *µ*M H~2~O~2~, 30 *µ*M GP, NC vector or siNrf2 vector for 24 h as aforementioned. Following treatment, cells were incubated with 2′,7′-dichlorofluorescein diacetate (Sigma-Aldrich; Merck KGaA) at 37°C for 30 min and then washed with PBS for three times. The levels of ROS were determined using a MoFlo flow cytometer (Beckman Coulter, Inc., Brea, CA, USA) and the data was analyzed using SUMMIT Software V4.3 (Dako; Agilent Technologies, Santa Clara, USA).

For the cell apoptosis assay, an Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) apoptosis detection kit (Dalian Meilunbio Biotechnology Co., Ltd., Dalian, China) was employed according to the manufacturer's protocols. Briefly, cells were seeded into 6-well plates (5×10^4^ cell/well) for 24 h. Then, cells were treated with 200 *µ*M H~2~O~2~, 30 *µ*M GP, NC vector and siNrf2 vector for 24 h as aforementioned. Following treatment, cells were digested with 0.25% EDTA-trypsin (Beijing Solarbio Science & Technology, Co., Ltd.) at room temperature for 2 min and resuspended in DMEM/F12. The cells were centrifuged at 1,000 × g for 5 min at 4°C, and then incubated with Annexin V-FITC and PI in darkness for 25 min at room temperature. Cell apoptosis was analyzed with a MoFlo flow cytometer (Beckman Coulter, Inc.) and the data was analyzed using SUMMIT Software V4.3. The number of apoptotic cells was calculated by adding data in the second and the fourth quadrants of the flow cytometry data.

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assay
----------------------------------------------------------------------------

Total RNA was extracted from cells using Trizol reagent (Thermo Fisher Scientific, Inc.) according to the manufacturer's protocols. RNA (1 *µ*g) was used to synthesize cDNA by using the Quantscript RT Kit (Promega Corporation, Madison, WI, USA) under the following conditions: 25°C for 10 min, 42°C for 50 min, 85°C for 15 min and 4°C for 10 min. cDNA was amplified using a SYBR Premix Taq™ II kit (Takara Bio, Inc., Otsu, Japan) on an ABI 7500 thermocycler (Applied Biosystems; Thermo Fisher Scientific, Inc.). The reaction conditions were as follows: 95°C for 3 min, followed by 30 cycles of at 95°C for 15 sec and at 62°C for 30 sec, and extension for 60 sec at 72°C. The sequences of primers were presented in [Table I](#tI-ijmm-43-02-0936){ref-type="table"}. GAPDH was used as an internal control. The quantification of gene expression was performed using the 2^−ΔΔCq^ method ([@b21-ijmm-43-02-0936]).

Western blot analysis
---------------------

Cells were lysed with radioimmunoprecipitation assay buffer (Beijing Solarbio Science & Technology, Co., Ltd.) to obtain protein extracts. A Bradford's protein assay kit (Beyotime Institute of Biotechnology) was employed to detect the concentrations of protein extracts. Each protein (25 *µ*g per lane) was separated by 10% SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Merck KGaA). The membrane was blocked using tris-buffered saline with TBS solution (0.05% Tween-20) containing 5% non-fat milk for 1 h at 4°C. The membrane was incubated with anti-HO-1 (AF3169, 1:600; R&D Systems, Inc., Minneapolis, MN, USA), anti-Nrf2 (MAB3925, 1:800; R&D Systems, Inc.), anti-NQO1 (AF7567, 1:1,200; R&D Systems, Inc.), anti-cleaved-caspase-3 (AF835, 1:1,000; R&D Systems, Inc.), anti-B-cell lymphoma-2 (Bcl-2; AF810, 1:800; R&D Systems, Inc.), anti-Bcl-2 associated X (Bax; AF820, 1:1,000; R&D Systems, Inc.) and anti-GAPDH (2275-PC-100, 1:600; R&D Systems, Inc.) at 4°C overnight. Then, the membrane was washed with TBST for three times. Following washing, the membrane was incubated with corresponding secondary antibodies \[rabbit anti-goat IgG-horseradish peroxidase (HRP), sc-2768, 1:6,000; mouse anti-rabbit, IgG-HRP, sc-2357, 1:7,000; donkey anti-goat IgG-HRP, sc-2020, 1:8,000; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) at 37°C for 60 min. The membrane was washed with TBST for three times. Subsequently, the proteins were detected by using an enhanced chemiluminescence detection reagent (GE Healthcare, Chicago, IL, USA)and exposed under an E-Gel Imager (Invitrogen; Thermo, Fisher, Scientific, Inc.). The blot density was analyzed by Quantity One software version 4.6.2 (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

Statistical analysis
--------------------

The data were presented as the mean ± standard deviation using SPSS software (version 20; IBM, Corp., Armonk, NY, USA). The differences among groups were assessed by one-way analysis of variance followed by a Tukey's post hoc test. All the experiment was independently conducted at least for three times. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

GP alleviates decreased viability of ARPE-19 cells induced by H~2~O~2~
----------------------------------------------------------------------

To investigate the effects of GP and H~2~O~2~ on the viability of ARPE-19 cells, an MTT assay was conducted to determine cell viability. The results revealed that cell viability was significantly suppressed in response to treatment with 200, 400 and 800 *µ*M H~2~O~2~ compared with the control ([Fig. 1A](#f1-ijmm-43-02-0936){ref-type="fig"}), while 30, 50 and 100 *µ*M GP significantly promoted cell viability compared with the control; the increased cell viability at 30 *µ*M GP was similar to that of 50 and 100 *µ*M ([Fig. 1B](#f1-ijmm-43-02-0936){ref-type="fig"}). Therefore, 100 and 200 *µ*M H~2~O~2~ and 5, 10, 30 *µ*M GP was selected to further detect the effects of GP on H~2~O~2~-treated cells. Upon treatment with H~2~O~2~ (10, 50 and 100 *µ*M) or GP (5 and 10 *µ*M), no notable alterations in cell viability were observed. Treatment with 200 *µ*M H~2~O~2~ and GP (0, 5, 10 and 30 *µ*M) exhibited significantly reduced cell viability compared with the untreated control ([Fig. 1C](#f1-ijmm-43-02-0936){ref-type="fig"}). No significant difference was observed between the GP + 200 *µ*M H~2~O~2~ and GP + 100 *µ*M H~2~O~2~ groups. Thus, 30 *µ*M GP was used to treat cells for subsequent experiments. The present study reported that cell viability was significantly increased in the 30 *µ*M GP + 200 *µ*M H~2~O~2~ group compared with the 200 *µ*M H~2~O~2~ group ([Fig. 1C](#f1-ijmm-43-02-0936){ref-type="fig"}). The results indicated that GP increased the viability of H~2~O~2~-treated cells.

GP suppresses the effects of H~2~O~2~ on the levels of ROS and apoptosis of ARPE-19 cells by activating Nrf2 signaling
----------------------------------------------------------------------------------------------------------------------

Oxidative stress is an important cause of injury to RPE cells ([@b22-ijmm-43-02-0936]). To analyze the effects of GP on H~2~O~2~-induced ARPE-19 cell injury, the ROS levels, cell apoptosis and Nrf2 signaling were detected. The data of flow cytometry revealed that ROS levels and the number of apoptotic cells were significantly enhanced in cells treated with H~2~O~2~ compared with in untreated and H~2~O~2~-induced cells treated with GP ([Fig. 2A](#f2-ijmm-43-02-0936){ref-type="fig"}). In addition, H~2~O~2~ significantly reduced the protein expression levels of Nrf2, HO-1 and NQO1, and the mRNA expression levels of HO-1 and NQO1 compared with the control ([Fig. 2B-D](#f2-ijmm-43-02-0936){ref-type="fig"}). On the contrary, treatment with GP significantly increased the expression of Nrf2, HO-1 and NQO1 in H~2~O~2~-induced cells compared with H~2~O~2~ treatment alone ([Fig. 2B-D](#f2-ijmm-43-02-0936){ref-type="fig"}). The results suggested that GP suppressed H~2~O~2~-induced RPE cell injuries.

Nrf2 silencing enhances H~2~O~2~-induced damage to ARPE-19 cells
----------------------------------------------------------------

In the present study, to determine the effects of Nrf2 on ARPE cells, cell viability and the expression levels of Nrf2, HO-1 and NQO1 were respectively analyzed by an MTT assay, RT-qPCR and western blotting. When cells were transfected with siRNA Nrf2 vector, no notable alterations in cell viability were observed ([Fig. 3A](#f3-ijmm-43-02-0936){ref-type="fig"}). As the demonstrated by western blotting, the expression levels of NQO1, HO-1 and Nrf2 proteins were significantly suppressed in the siNrf2 group compared with in the NC group ([Fig. 3B and C](#f3-ijmm-43-02-0936){ref-type="fig"}). In addition, the mRNA expression profiles of NQO1 and HO-1 were similar to the protein expression profile in each group ([Fig. 3D](#f3-ijmm-43-02-0936){ref-type="fig"}). In order to further investigate the effects of siNrf2 on ARPE cells induced by H~2~O~2~, the ROS levels, cell apoptosis and Nrf2 signaling were analyzed. The present study reported that siNrf2 significantly and markedly enhanced the ROS levels and apoptosis in ARPE-19 cells induced by H~2~O~2~, respectively, compared with the H~2~O~2~ + NC group ([Fig. 4A](#f4-ijmm-43-02-0936){ref-type="fig"}). The expression levels of apoptosis-associated factors were evaluated by RT-qPCR and western blotting. SiNrf2 significantly downregulated the expression levels of Nrf2, NQO1 and HO-1 in cells treated with H~2~O~2~, compared with the H~2~O~2~ + NC group ([Fig. 4B, C and E](#f4-ijmm-43-02-0936){ref-type="fig"}). The results also revealed that, compared with the H~2~O~2~ and H~2~O~2~ + NC groups, siNfr2-transfected cells treated with H~2~O~2~ exhibited increased Bax and cleaved-caspase-3 expression levels; the protein expression levels of Bcl-2 were significantly decreased in the H~2~O~2~ + siNrf2 group compared with the H~2~O~2~ and H~2~O~2~ + NC groups ([Fig. 4D and F](#f4-ijmm-43-02-0936){ref-type="fig"}). These results suggested that Nrf2 knockdown enhanced H~2~O~2~-induced RPE cell injury.

Nrf2 silencing attenuates the protective effects of GP on H~2~O~2~-induced ARPE-19 cells
----------------------------------------------------------------------------------------

In the present study, the role of Nrf2 in GP-induced-effects on H~2~O~2~-treated cells was investigated. Flow cytometry revealed that, compared with the H~2~O~2~ + GP + NC group, the ROS levels and number of apoptotic cells were significantly increased in the H~2~O~2~ + GP + siNrf2 group; GP significantly decreased ROS levels and apoptosis in H~2~O~2~-induced cells compared with H~2~O~2~ treatment alone ([Fig. 5A](#f5-ijmm-43-02-0936){ref-type="fig"}). When cells were exposed to GP and siNrf2 vector, the protein expression levels of Nrf2, NQO1, HO-1, and Bcl-2 were significantly downregulated, while that of Bax and cleaved-caspase-3 were significantly upregulated, compared with the GP group. Additionally, compared with the H~2~O~2~ + GP + NC group, the expression of Nrf2, NQO1, HO-1, and Bcl-2 were inhibited in the H~2~O~2~ + GP + siNrf2 group; the protein expression levels of Bax and cleaved-caspase-3 were notably and significantly increased, respectively ([Fig. 5B-D](#f5-ijmm-43-02-0936){ref-type="fig"}). The mRNA expression profile of Nrf2, NQO1, HO-1, Bcl-2 and Bax was similar to their respective trend in protein levels ([Fig. 5E and F](#f5-ijmm-43-02-0936){ref-type="fig"}). The results of the present study suggested that the activation of Nrf2 signaling was associated with the protective effects of GP on H~2~O~2~-treated RPE cells.

Discussion
==========

Oxidative stress is one of the most important mechanisms underlying the pathogenesis of AMD ([@b3-ijmm-43-02-0936]). Oxidative damage of RPE is a key process in the pathogenesis of AMD ([@b4-ijmm-43-02-0936]). H~2~O~2~ can induce the production of ROS in cells, leading to oxidative damage ([@b23-ijmm-43-02-0936]). Exogenous H~2~O~2~ treatment is a simple and feasible cell model for studying RPE oxidative damage, which can effectively simulate the process of oxidative damage of RPE in AMD ([@b24-ijmm-43-02-0936],[@b25-ijmm-43-02-0936]). Therefore, in the present study, H~2~O~2~ was selected as an inducer of oxidative damage to ARPE-19 cells. Additionally, 200 *µ*M H~2~O~2~ was identified as the optimal concentration to generate a cellular oxidative damage model.

GP has been demonstrated to prevent or treat cardiovascular diseases, diabetes, nervous system diseases, pathogenic infections and inflammation ([@b26-ijmm-43-02-0936]-[@b30-ijmm-43-02-0936]). Lin *et al* ([@b28-ijmm-43-02-0936]) reported that GP protected renal tissue from oxidative stress-associated injury by suppressing oxidative stress and apoptosis. Shin and Lee ([@b29-ijmm-43-02-0936]) proposed that GP improved age-associated insulin resistance by reducing oxidative stress in LO2 cells; however, the role of GP in AMD remains unclear. In the present study, it was suggested that GP exerted a protective effect on H~2~O~2~-induced oxidative damage of ARPE-19 cells. The results of the present study revealed that GP (30, 50 and 100 *µ*M) significantly increased the viability of ARPE-19 cells, indicating that the treatment of GP may induce some survival signals in ARPE-19 cells; the increased cell viability in response to 30 *µ*M GP was similar to that of 50 and 100 *µ*M. Therefore, low, moderate and high concentrations of GP (5, 10 and 30 *µ*M) were selected to analyze cell viability inhibited by H~2~O~2~. The data demonstrated that 30 *µ*M GP significantly enhanced cell viability. Hence, 30 *µ*M GP was determined to be the optimal concentration for analysis in the present study. The observations of the present study suggested that GP exerted a protective effect on H~2~O~2~-induced oxidative damage of ARPE-19 cells by enhancing cell viability.

Oxidative damage is caused by the imbalance of the intracellular redox state, which generates a large amount of active oxygen and produces free radicals ([@b31-ijmm-43-02-0936]). Providing the concentration of ROS exceeds the clearance capacity of the body, tissue or cell damage may occur ([@b32-ijmm-43-02-0936],[@b33-ijmm-43-02-0936]). It has been reported that antioxidant genes and drugs inhibit H~2~O~2~-induced oxidative damage by decreasing ROS activity ([@b26-ijmm-43-02-0936],[@b34-ijmm-43-02-0936]-[@b37-ijmm-43-02-0936]). Studies have demonstrated that oxidative stress injury is one of the important factors of apoptosis ([@b38-ijmm-43-02-0936]-[@b40-ijmm-43-02-0936]). Radi *et al* ([@b39-ijmm-43-02-0936]) have reported that taxifolin alleviated H~2~O~2~-induced oxidative stress injury of ARPE-19 cells by inhibiting apoptosis. Therefore, ROS levels and the apoptosis of ARPE-19 cells treated with H~2~O~2~ and GP were analyzed by flow cytometry in the present study. Similar to previous reports ([@b34-ijmm-43-02-0936],[@b36-ijmm-43-02-0936],[@b37-ijmm-43-02-0936],[@b41-ijmm-43-02-0936]), the results of the present study revealed that GP significantly reduced the levels of ROS and apoptosis in ARPE-19 cells induced by H~2~O~2~. In addition, GP significantly suppressed the expression of Bax and cleaved-caspase 3, and promoted Bcl-2 expression. These observations indicated that GP opposed the effects of H~2~O~2~ on ARPE-19 cell injury via anti-apoptosis and antioxidation.

Nrf2 signaling serves a key role in regulating antioxidant enzymes, and is also an important part of maintaining oxidative and antioxidative homeostasis, and alleviating oxidative stress damage ([@b42-ijmm-43-02-0936]). HO-1 and NQO1 are the key downstream factors of Nrf2 signaling, and serve an important role in protecting cells from oxidative damage ([@b43-ijmm-43-02-0936],[@b44-ijmm-43-02-0936]). Hu *et al* ([@b43-ijmm-43-02-0936]) indicated that microRNA-455 activated the Nrf2 signaling pathway to protect osteoblasts against H~2~O~2~-induced injury. Vurusaner *et al* ([@b44-ijmm-43-02-0936]) proposed that laminarin ameliorated H~2~O~2~-induced MRC-5 cell oxidative injury by promoting the Nrf2 signaling pathway ([@b45-ijmm-43-02-0936]). Previous studies have also reported the beneficial effects of the Nrf2 signaling pathway on RPE cells ([@b46-ijmm-43-02-0936],[@b47-ijmm-43-02-0936]). In the present study, it was proposed that the potential antioxidative mechanism of GP may comprise Nrf2 signaling. The results demonstrated that GP reversed the inhibitory effects of H~2~O~2~ on the expression of Nrf2, HO-1 and NQO1 in ARPE-19 cells. In addition, the effects of Nrf2 on ARPE-19 cells were investigated in the present study. The results revealed that Nrf2 knockdown exhibited no toxicity to cells; the effects of Nrf2 knockdown may be mainly produced on the molecular level rather than at the cellular level. However, Nrf2 silencing enhanced the effects of H~2~O~2~ on inducing cell damage via increasing ROS levels and apoptosis. Furthermore, Nrf2 silencing attenuated the protective effects of GP on H~2~O~2~-induced ARPE-19 cell injury by promoting apoptosis and oxidation. Therefore, the activation of Nrf2 signaling may be closely associated with the protective effects of GP. In addition, it has been reported that GP suppressed the growth of breast cancer cells by inhibiting UCP2 ([@b14-ijmm-43-02-0936]). Thus, it is possible that other signals may also associate with the protective effects of GP.

In summary, the present study proposed the novel functions of GP, which protected ARPE-19 cells against oxidative damage induced by H~2~O~2~ via promoting cell viability and suppressing ROS levels and apoptosis. The molecular mechanism was associated with the activation of Nrf2 signaling. These results suggested that GP may be considered as a therapeutic agent for the treatment and prevention of AMD.
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![GP alleviates decreased viability of ARPE-19 cells induced by H~2~O~2~. (A-C) ARPE-19 cells were exposed to various concentrations of H~2~O~2~ (0, 10, 50, 100, 200, 400+ and 800 *µ*M) and GP (0, 5, 10, 30, 50 and 100 *µ*M). Cell viability was assessed by an MTT assay. ^\*^P\<0.05, ^\*\*^P\<0.01, vs. 0 *µ*M group. ^\#^P\<0.05, vs. 200 *µ*M H~2~O~2~ group. n=5. GP, genipin.](IJMM-43-02-0936-g00){#f1-ijmm-43-02-0936}

![GP suppresses the effects of H~2~O~2~ on the levels of ROS and apoptosis of ARPE-19 cells by activating Nrf2 signaling. (A) ARPE-19 cells were exposed to 200 *µ*M H~2~O~2~ and 30 *µ*M GP. The ROS levels and apoptosis were assessed by flow cytometry. (B and C) Protein expression levels of Nrf2, HO-1 and NQO1 were evaluated by western blotting. (D) mRNA expression levels of HO-1 and NQO1 were detected by reverse transcription-quantitative polymerase chain reaction. ^\*^P\<0.05, ^\*\*^P\<0.01. n=4. FITC, fluorescein isothiocyanate; GP, genipin; HO-1, heme oxygenase-1; NQO1, NAD(P)H: Quinine oxidoreductase; Nrf2, nuclear factor-erythroid 2-related factor-2; PI, propidium iodide; ROS, reactive oxygen species.](IJMM-43-02-0936-g01){#f2-ijmm-43-02-0936}

![Nrf2 downregulation inhibits the expression of downstream target genes NQO1 and HO-1 in ARPE-19 cells. (A) ARPE-19 cells were transfected with siNC and siNrf2 vectors using Lipofectamine^®^ 3000. Cell viability was analyzed by an MTT assay. (B and C) Western blotting was applied to detect the expression of Nrf2, HO-1 and NQO1 proteins. (D) Reverse transcription-quantitative polymerase chain reaction was performed to detect the expression of HO-1 and NQO1 mRNA. ^\*^P\<0.05, ^\*\*^P\<0.01. n=4. HO-1, heme oxygenase-1; NQO1, NAD(P)H: Quinine oxidoreductase; Nrf2, nuclear factor-erythroid 2-related factor-2; siRNA, small interfering RNA; siNC, siRNA negative control; siNrf2, siRNA Nrf2.](IJMM-43-02-0936-g02){#f3-ijmm-43-02-0936}

###### 

Nrf2 silencing enhances H~2~O~2~-induced damage to ARPE-19 cells. (A) ARPE-19 cells were subjected to treatment with 200 *µ*M H~2~O~2~, NC vector and siNrf2 vector. Flow cytometry was performed to analyze the levels of ROS and the number of apoptotic cells. ^\*^P\<0.05 vs. H~2~O~2~ + NC group. (B) Proteins expression levels of Nrf2, were determined using western blotting. (C) The protein expression levels of NQO1 and HO-1 were detected by reverse transcription-quantitative polymerase chain reaction. (D) The protein expression levels of cleaved-caspase 3, Bax and Bcl-2 were detected by western blotting. (E) The mRNA expression levels of HO-1 and NQO1 were detected by reverse transcription-quantitative polymerase chain reaction. (F) The mRNA expression levels of Bax and Bcl-2 were detected by reverse transcription-quantitative polymerase chain reaction. ^\*^P\<0.05, ^\*\*^P\<0.01. n=4. Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X; FITC, fluorescein isothiocyanate; HO-1, heme oxygenase-1; NQO1, NAD(P)H: Quinine oxidoreductase; Nrf2, nuclear factor-erythroid 2-related factor-2; PI, propidium iodide; siRNA, small interfering RNA; NC, siRNA negative control; siNrf2, siRNA Nrf2.
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###### 

Nrf2 silencing attenuates the effects of GP on H~2~O~2~-induced ARPE-19 cells. (A) ARPE-19 cells were subjected to treatment with 200 *µ*M H~2~O~2~, 30 *µ*M GP, NC vector and siNrf2 vector. Flow cytometry was applied to analyze the levels of ROS and the number of apoptotic cells. ^\*^P\<0.05, ^\*\*^P\<0.01. (B-D) Proteins expression levels of Nrf2, HO-1, NQO1, Bax, Bcl-2 and cleaved-caspase 3 were determined by western blotting. (E and F) mRNA expression levels of HO-1, NQO1, Bax and Bcl-2 were detected by reverse transcription-quantitative polymerase chain reaction. ^\*^P\<0.05, ^\*\*^P\<0.01. n=4. Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X; FITC, fluorescein isothiocyanate; HO-1, heme oxygenase-1; NQO1, NAD(P)H: Quinine oxidoreductase; Nrf2, nuclear factor-erythroid 2-related factor-2; PI, propidium iodide; siNrf2, small interfering RNA Nrf2.

![](IJMM-43-02-0936-g05)

![](IJMM-43-02-0936-g06)

###### 

Sequences of the primers employed for reverse transcription-quantitative polymerase chain reaction.

  Primer          Sequence (5′-3′)
  --------------- ----------------------
  HO-1-forward    CGTTCCTGCTCAACATCCAG
  HO-1-reverse    TGAGTGTAAGGACCCATCGG
  NQO1-forward    AGAAAGGATGGGAGGTGGTG
  NQO1-reverse    ATATCACAAGGTCTGCGGCT
  Bax-forward     AACATGGAGCTGCAGAGGAT
  Bax-reverse     CCAATGTCCAGCCCATGATG
  Bcl-2-forward   TTCTTTGAGTTCGGTGGGGT
  Bcl-2-reverse   CTTCAGAGACAGCCAGGAGA
  GAPDH-forward   CCATCTTCCAGGAGCGAGAT
  GAPDH-reverse   TGCTGATGATCTTGAGGCTG

Bax, Bcl-2-associated X; HO-1, heme oxygenase 1; NQO1, NAD(P)H: Quinine oxidoreductase 1.
